{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:48:40Z","timestamp":1791204520435,"version":"4.2.0"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>HMGB1-NLRP3 mediated pyroptosis was recently discovered to be a pathogenic cause of ischemic stroke. Our previous research has demonstrated the anti-inflammatory and anti-apoptotic properties of calycosin in mitigating cerebral ischemia-reperfusion injury (CIRI). However, its specific effects on HMGB1-NLRP3-mediated pyroptosis in ischemic stroke remain unclear. This study investigated the efficacy of calycosin in reducing pyroptosis-linked CIRI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:italic>In vivo<\/jats:italic>, a rat model of middle cerebral artery occlusion (MCAO) received varying doses of intracerebroventricular calycosin. Therapeutic efficacy was assessed using neurological deficit scores, TTC staining, H-E staining, Nissl staining, and immunohistochemistry. <jats:italic>In vitro<\/jats:italic>, HAPI microglial cells were subjected to oxygen-glucose deprivation\/reoxygenation (OGD\/R) and then treated with calycosin, HMGB1 siRNA, or MCC950. Cell survival was evaluated using the CCK8 assay. Ultrastructural changes were examined through transmission and scanning electron microscopy. Inflammatory cytokine levels were quantified by ELISA. The expression of pyroptosis-related proteins and genes was analyzed using Western blot and qRT-PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Discussion<\/jats:title><jats:p>Calycosin significantly reduced neurological impairments and brain infarction in a dose-dependent manner, alleviated neuronal damage and decreased the expression of pyroptosis-related markers, including NLRP3, GSDMD, HMGB1, IL-1\u03b2, IL-18, and caspase-1. These results indicate that calycosin enhances microglial cell survival and mitigates pyroptotic damage by inhibiting NLRP3 inflammasome activation, suggesting its potential as a neuroprotective therapy for ischemic stroke through the modulation of the HMGB1-dependent pyroptosis pathway.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1596087","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:41:53Z","timestamp":1750225313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Intracerebroventricular calycosin attenuates cerebral ischemia-reperfusion injury in rats via HMGB1-dependent pyroptosis inhibition"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiguang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiquan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/bpa.12476","article-title":"A brain in flame; do inflammasomes and pyroptosis influence stroke pathology?","volume":"27","author":"Barrington","year":"2017","journal-title":"Brain Pathol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41419-021-04379-z","article-title":"NLPR3 inflammasome inhibition alleviates hypoxic endothelial cell death in vitro and protects blood-brain barrier integrity in murine stroke","volume":"13","author":"Bellut","year":"2021","journal-title":"Cell Death Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"107623","DOI":"10.1016\/j.intimp.2021.107623","article-title":"Sepsis-induced acute lung injury in young rats is relieved by calycosin through inactivating the HMGB1\/MyD88\/NF-\u03baB pathway and NLRP3 inflammasome","volume":"96","author":"Chen","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1080\/14787210.2021.1863145","article-title":"Calycosin: a review of its pharmacological effects and application prospects","volume":"19","author":"Deng","year":"2021","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"110222","DOI":"10.1016\/j.intimp.2023.110222","article-title":"Panaxynol ameliorates cardiac ischemia\/reperfusion injury by suppressing NLRP3-induced pyroptosis and apoptosis via HMGB1\/TLR4\/NF-\u03baB axis","volume":"121","author":"Ding","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1089\/ars.2020.8257","article-title":"Loop between NLRP3 inflammasome and reactive oxygen species","volume":"36","author":"Dominic","year":"2022","journal-title":"Antioxid. Redox Signal"},{"key":"B8","doi-asserted-by":"publisher","first-page":"154432","DOI":"10.1016\/j.phymed.2022.154432","article-title":"LC-MS\/MS combined with blood-brain dual channel microdialysis for simultaneous determination of active components of astragali radix-safflower combination and neurotransmitters in rats with cerebral ischemia reperfusion injury: application in pharmacokinetic and pharmacodynamic study","volume":"106","author":"Du","year":"2022","journal-title":"Phytomedicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2410404","DOI":"10.1002\/smll.202410404","article-title":"Nanoparticles designed based on the blood-brain barrier for the treatment of cerebral ischemia-reperfusion injury","volume":"21","author":"Du","year":"2025","journal-title":"Small"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1474-4422(23)00277-6","article-title":"Pragmatic solutions to reduce the global burden of stroke: a world stroke organization-lancet neurology commission","volume":"22","author":"Feigin","year":"2023","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbi.2020.12.009","article-title":"The NLRP3 inflammasome drives inflammation in ischemia\/reperfusion injury after transient middle cerebral artery occlusion in mice","volume":"92","author":"Franke","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jep.2012.09.056","article-title":"Neuroprotective effect of calycosin on cerebral ischemia and reperfusion injury in rats","volume":"144","author":"Guo","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.3390\/cells10071639","article-title":"Glial cells as therapeutic approaches in brain ischemia-reperfusion injury","volume":"10","author":"Hernandez","year":"2021","journal-title":"Cells"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e70036","DOI":"10.1111\/1440-1681.70036","article-title":"Electroacupuncture attenuates cerebral ischemia-reperfusion injury by inhibiting ferroptosis via the p53\/SLC7A11 pathway","volume":"52","author":"Hou","year":"2025","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s11481-019-09903-9","article-title":"Calycosin preserves BDNF\/TrkB signaling and reduces post-stroke neurological injury after cerebral ischemia by reducing accumulation of hypertrophic and TNF-alpha-containing microglia in rats","volume":"15","author":"Hsu","year":"2020","journal-title":"J. Neuroimmune Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1007\/s12035-021-02384-z","article-title":"Verapamil as an adjunct therapy to reduce tPA toxicity in hyperglycemic stroke: implication of TXNIP\/NLRP3 inflammasome","volume":"58","author":"Ismael","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/STROKEAHA.121.033448","article-title":"Ongoing advances in medical and interventional treatments of large vessel occlusion stroke","volume":"52","author":"Jadhav","year":"2021","journal-title":"Stroke"},{"key":"B18","doi-asserted-by":"publisher","first-page":"114676","DOI":"10.1016\/j.expneurol.2024.114676","article-title":"miR-96-5p alleviates cerebral ischemia-reperfusion injury in mice by inhibiting pyroptosis via downregulating caspase 1","volume":"374","author":"Jin","year":"2024","journal-title":"Exp. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cytogfr.2024.06.002","article-title":"The impact of cytokines in neuroinflammation-mediated stroke","volume":"78","author":"Kumari","year":"2024","journal-title":"Cytokine Growth Factor Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s12975-024-01258-5","article-title":"HMGB1: a New target for ischemic stroke and hemorrhagic transformation","volume":"16","author":"Li","year":"","journal-title":"Transl. Stroke Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12974-023-02819-5","article-title":"Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia\/reperfusion injury","volume":"20","author":"Li","year":"","journal-title":"J. Neuroinflammation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"112797","DOI":"10.1016\/j.jep.2020.112797","article-title":"Anti-tumor effects and mechanisms of Astragalus membranaceus (AM) and its specific immunopotentiation: status and prospect","volume":"258","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3724\/abbs.2023125","article-title":"Calycosin attenuates the inflammatory damage of microglia induced by oxygen and glucose deprivation through the HMGB1\/TLR4\/NF-kappaB signaling pathway","volume":"55","author":"Li","year":"","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jconrel.2024.02.039","article-title":"Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke","volume":"368","author":"Li","year":"","journal-title":"J. Control Release"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1162134","DOI":"10.3389\/fphar.2023.1162134","article-title":"Neuroprotective effect of Astragali Radix on cerebral infarction based on proteomics","volume":"14","author":"Li","year":"","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"115968","DOI":"10.1016\/j.bcp.2023.115968","article-title":"Acteoside alleviates blood-brain barrier damage induced by ischemic stroke through inhibiting microglia HMGB1\/TLR4\/NLRP3 signaling","volume":"220","author":"Liao","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"113664","DOI":"10.1016\/j.ecoenv.2022.113664","article-title":"HMGB1-NLRP3-P2X7R pathway participates in PM(2.5)-induced hippocampal neuron impairment by regulating microglia activation","volume":"239","author":"Liu","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"B28","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jep.2016.10.058","article-title":"Effects of the traditional Chinese herb Astragalus membranaceus in patients with poststroke fatigue: a double-blind, randomized, controlled preliminary study","volume":"194","author":"Liu","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"109488","DOI":"10.1016\/j.abb.2022.109488","article-title":"Calycosin decreases cerebral ischemia\/reperfusion injury by suppressing ACSL4-dependent ferroptosis","volume":"734","author":"Liu","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"B30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fnagi.2017.00233","article-title":"Curcumin protects against ischemic stroke by titrating microglia\/macrophage polarization","volume":"9","author":"Liu","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41420-023-01440-y","article-title":"Targeting pyroptosis as a preventive and therapeutic approach for stroke","volume":"9","author":"Long","year":"2023","journal-title":"Cell Death Discov."},{"key":"B32","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1161\/01.str.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"key":"B33","doi-asserted-by":"publisher","first-page":"113776","DOI":"10.1016\/j.jep.2021.113776","article-title":"Salvianolic Acids for Injection alleviates cerebral ischemia\/reperfusion injury by switching M1\/M2 phenotypes and inhibiting NLRP3 inflammasome\/pyroptosis axis in microglia in vivo and in vitro","volume":"270","author":"Ma","year":"","journal-title":"J. Ethnopharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/10717544.2021.1879315","article-title":"Targeted nano-delivery strategies for facilitating thrombolysis treatment in ischemic stroke","volume":"28","author":"Ma","year":"","journal-title":"Drug Deliv."},{"key":"B35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/pharmrev.122.000629","article-title":"Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction","volume":"75","author":"Ma","year":"2023","journal-title":"Pharmacol. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/s41375-019-0436-6","article-title":"NLRP3 inflammasome couples purinergic signaling with activation of the complement cascade for the optimal release of cells from bone marrow","volume":"33","author":"Ratajczak","year":"2019","journal-title":"Leukemia"},{"key":"B37","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/STROKEAHA.123.043764","article-title":"CNS drug delivery in stroke: improving therapeutic translation from the bench to the bedside","volume":"55","author":"Ronaldson","year":"2024","journal-title":"Stroke"},{"key":"B38","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/cpt.2531","article-title":"Translational approaches for brain delivery of biologics via cerebrospinal fluid","volume":"111","author":"Sadekar","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"B39","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.2147\/DDDT.S272355","article-title":"Astragaloside IV: an effective drug for the treatment of cardiovascular diseases","volume":"14","author":"Tan","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bioactmat.2022.05.012","article-title":"Targeted alleviation of ischemic stroke reperfusion via atorvastatin-ferritin Gd-layered double hydroxide","volume":"20","author":"Wang","year":"2023","journal-title":"Bioact. Mater"},{"key":"B41","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41419-021-03725-5","article-title":"Mitochondrial ferritin attenuates cerebral ischaemia\/reperfusion injury by inhibiting ferroptosis","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1159\/000487031","article-title":"Neuroprotective mechanisms of calycosin against focal cerebral ischemia and reperfusion injury in rats","volume":"45","author":"Wang","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B43","doi-asserted-by":"publisher","first-page":"690549","DOI":"10.3389\/fphar.2021.690549","article-title":"Calycosin alleviates sepsis-induced acute lung injury via the inhibition of mitochondrial ROS-mediated inflammasome activation","volume":"12","author":"Xia","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"154845","DOI":"10.1016\/j.phymed.2023.154845","article-title":"Calycosin alleviates cerebral ischemia\/reperfusion injury by repressing autophagy via STAT3\/FOXO3a signaling pathway","volume":"115","author":"Xu","year":"2023","journal-title":"Phytomedicine"},{"key":"B45","doi-asserted-by":"publisher","first-page":"8798069","DOI":"10.1155\/2019\/8798069","article-title":"Calycosin-7-O-\u03b2-D-glucoside attenuates OGD\/R-Induced damage by preventing oxidative stress and neuronal apoptosis via the SIRT1\/FOXO1\/PGC-1\u03b1 pathway in HT22 cells","volume":"2019","author":"Yan","year":"2019","journal-title":"Neural Plast."},{"key":"B46","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/jcbfm.2013.242","article-title":"NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke","volume":"34","author":"Yang","year":"2014","journal-title":"J. Cereb. Blood Flow. Metab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13020-023-00789-7","article-title":"Research on the interaction of astragaloside IV and calycosin in Astragalus membranaceus with HMGB1","volume":"18","author":"Ye","year":"2023","journal-title":"Chin. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fncel.2019.00553","article-title":"Meisoindigo protects against focal cerebral ischemia-reperfusion injury by inhibiting NLRP3 inflammasome activation and regulating microglia\/macrophage polarization via TLR4\/NF-\u03baB signaling pathway","volume":"13","author":"Ye","year":"2019","journal-title":"Front. Cell Neurosci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-023-00636-1","article-title":"Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease","volume":"18","author":"Yu","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"B50","doi-asserted-by":"publisher","first-page":"177621","DOI":"10.1016\/j.ejphar.2025.177621","article-title":"Calycosin treats acute myocardial infarction via NLRP3 inflammasome: bioinformatics, network pharmacology and experimental validation","volume":"997","author":"Yuan","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7448","DOI":"10.1007\/s12035-024-04050-6","article-title":"Neuroinflammation targeting pyroptosis: molecular mechanisms and therapeutic perspectives in stroke","volume":"61","author":"Yuan","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"10792","DOI":"10.1007\/s12035-024-04225-1","article-title":"Activation of inflammasomes and relevant modulators for the treatment of microglia-mediated neuroinflammation in ischemic stroke","volume":"61","author":"Zeng","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1333006","DOI":"10.3389\/fphar.2024.1333006","article-title":"Exploring Chinese herbal medicine for ischemic stroke: insights into microglia and signaling pathways","volume":"15","author":"Zhang","year":"","journal-title":"Front. Pharmacol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e14456","DOI":"10.1111\/cns.14456","article-title":"Neutral polysaccharide from Gastrodia elata alleviates cerebral ischemia-reperfusion injury by inhibiting ferroptosis-mediated neuroinflammation via the NRF2\/HO-1 signaling pathway","volume":"30","author":"Zhang","year":"","journal-title":"CNS Neurosci. Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.2147\/DDDT.S257020","article-title":"Pharmacokinetic analysis of huangqi guizhi wuwu decoction on blood and brain tissue in rats with normal and cerebral ischemia-reperfusion injury by microdialysis with HPLC-MS\/MS","volume":"14","author":"Zheng","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"7669","DOI":"10.3748\/wjg.v27.i44.7669","article-title":"Calycosin attenuates severe acute pancreatitis-associated acute lung injury by curtailing high mobility group box 1 - induced inflammation","volume":"27","author":"Zhu","year":"","journal-title":"World J. Gastroenterol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"714943","DOI":"10.3389\/fimmu.2021.714943","article-title":"Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2\/STAT3 pathway inhibition","volume":"12","author":"Zhu","year":"","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1596087\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:41:56Z","timestamp":1750225316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1596087\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":57,"alternative-id":["10.3389\/fphar.2025.1596087"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1596087","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"article-number":"1596087"}}